Tobias Kolbitsch

Tobias Kolbitsch is a researcher in the Department of Internal Medicine II at the SALK Institute for Biological Studies. His primary research focus lies in cardiology, particularly in cardiac resynchronization therapy, hypertrophic cardiomyopathy, and calcium handling mechanisms in cardiac cells.

• University: SALK Institute for Biological Studies
• Department: Internal Medicine II - Division of Cardiology

His research explores the interplay between mitochondrial function, calcium signaling, and cardiac pathologies such as aortic valve stenosis, hypertrophic cardiomyopathy, and postoperative arrhythmias. Recent publications highlight his work on conduction proteins, fibrotic substrates, and MCU expression in ventricular hypertrophy.

Key trends in his publications include:

• Investigating calcium-handling proteins as biomarkers in cardiac diseases
• Comparative studies of aortic valve stenosis and hypertrophic cardiomyopathy
• Understanding mosaicism in cardiac resynchronization therapy responders
• Postoperative ventricular arrhythmia prediction

Kolbitsch collaborates extensively with researchers across disciplines, as evidenced by co-authorships in journals like Journal of Clinical Medicine and Frontiers in Pharmacology. No formal awards or student advising details are publicly available in the provided data.